RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Taiko Pharmaceutical Co Stock

Taiko Pharmaceutical Co ROA 2024

Taiko Pharmaceutical Co ROA

-0.27

Ticker

4574.T

ISIN

JP3442200006

In 2024, Taiko Pharmaceutical Co's return on assets (ROA) was -0.27, a -16.04% increase from the -0.33 ROA in the previous year.

Taiko Pharmaceutical Co Aktienanalyse

What does Taiko Pharmaceutical Co do?

Taiko Pharmaceutical Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Taiko Pharmaceutical Co's Return on Assets (ROA)

Taiko Pharmaceutical Co's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Taiko Pharmaceutical Co's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Taiko Pharmaceutical Co's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Taiko Pharmaceutical Co’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Taiko Pharmaceutical Co stock

What is the Return on Assets (ROA) of Taiko Pharmaceutical Co this year?

The Return on Assets (ROA) of Taiko Pharmaceutical Co is -0.27 undefined this year.

What was the ROA of Taiko Pharmaceutical Co compared to the previous year?

The ROA of Taiko Pharmaceutical Co has increased by -16.04% compared to the previous year.

What consequences do high ROA have for investors of Taiko Pharmaceutical Co?

A high ROA is advantageous for investors of Taiko Pharmaceutical Co, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Taiko Pharmaceutical Co?

A low ROA can be unfavorable for investors of Taiko Pharmaceutical Co as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Taiko Pharmaceutical Co affect the company?

An increase in ROA of Taiko Pharmaceutical Co can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Taiko Pharmaceutical Co impact the company?

A reduction in the ROA of Taiko Pharmaceutical Co can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Taiko Pharmaceutical Co?

Some factors that can influence the ROA of Taiko Pharmaceutical Co include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Taiko Pharmaceutical Co important for investors?

The ROA of Taiko Pharmaceutical Co is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Taiko Pharmaceutical Co take to improve ROA?

To improve ROA, Taiko Pharmaceutical Co can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Taiko Pharmaceutical Co pay?

Over the past 12 months, Taiko Pharmaceutical Co paid a dividend of 23.67 JPY . This corresponds to a dividend yield of about 5.84 %. For the coming 12 months, Taiko Pharmaceutical Co is expected to pay a dividend of 0 JPY.

What is the dividend yield of Taiko Pharmaceutical Co?

The current dividend yield of Taiko Pharmaceutical Co is 5.84 %.

When does Taiko Pharmaceutical Co pay dividends?

Taiko Pharmaceutical Co pays a quarterly dividend. This is distributed in the months of October, April, October, January.

How secure is the dividend of Taiko Pharmaceutical Co?

Taiko Pharmaceutical Co paid dividends every year for the past 0 years.

What is the dividend of Taiko Pharmaceutical Co?

For the upcoming 12 months, dividends amounting to 0 JPY are expected. This corresponds to a dividend yield of 0 %.

In which sector is Taiko Pharmaceutical Co located?

Taiko Pharmaceutical Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Taiko Pharmaceutical Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Taiko Pharmaceutical Co from 3/31/2021 amounting to 10 JPY, you needed to have the stock in your portfolio before the ex-date on 12/29/2020.

When did Taiko Pharmaceutical Co pay the last dividend?

The last dividend was paid out on 3/31/2021.

What was the dividend of Taiko Pharmaceutical Co in the year 2023?

In the year 2023, Taiko Pharmaceutical Co distributed 0 JPY as dividends.

In which currency does Taiko Pharmaceutical Co pay out the dividend?

The dividends of Taiko Pharmaceutical Co are distributed in JPY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Taiko Pharmaceutical Co

Our stock analysis for Taiko Pharmaceutical Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Taiko Pharmaceutical Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.